ARTICLES BY ERIC LARSON
Medtech Material Selection For Performance And Feel
When designing a medical device, material selection can be difficult, especially with thousands of plastic material options available. While material properties, environmental effects, regulatory requirements, and cost almost always are considered, "feel" is often overlooked – despite its importance to user and patient satisfaction, as well as market success.
Continue Reading..
Medical Plastics: Material Selection Based On Feel
From prioritizing material properties to establishing desired values for each property, selecting plastic materials based on feel is a complicated undertaking. To elicit the most desirable user response from the device, it can be helpful to consider the what, rather than the how.
Continue Reading..
Spanish Is Not One Regulatory Language
Medical device manufacturers with regulatory plans in Latin America often treat translation as a procurement task. But is the translated document usable by the regulator and other key entities in the country in question?
Continue Reading..
09.03.26 -- Is Your Team Ready For AI-Assisted FDA Inspections?
09/03/26 Med Device Online Newsletter
Continue Reading..
AI-Readiness In A Regulated World: A Practical Playbook For Life Sciences
Uncover how life science teams build defensible governance, maintain human oversight, and manage regulatory risks when adopting advanced digital tools.
Continue Reading..
Advancing Biopsy Device Performance Through Precision Overmolding And Assembly
Early design alignment resolves tolerance stack-ups, controls mechanical variation, and maintains sample accuracy. Navigating process validation and automated assembly accelerates commercialization.
Continue Reading..
Six Key Challenges When Precision Has To Scale
Early design alignment resolves tolerance stack-ups, controls mechanical variation, and maintains sample accuracy. Navigating process validation and automated assembly accelerates commercialization.
Continue Reading..
POC Diagnostics: 4 Considerations For Bridging The Gap From Development To Commercialization
Scaling point-of-care diagnostics requires integrating microfluidics, chemistry, and automated assembly early in development. Aligning these pillars reduces risk and speeds time-to-market.
Continue Reading..
09.01.26 -- Optimize Your eQMS And Strengthen Quality Systems
09/01/26 Med Device Online Newsletter
Continue Reading..
The New Reality Of Particulate Risk: What Drug Manufacturers Need To Know
Particulate-related recalls account for 37% of US FDA injectable drug actions, and evolving FDA and EU GMP requirements are raising the compliance bar for manufacturers.
Continue Reading..